PUBLIC COMPANY
saveLuminary Therapeutics Inc
updated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma
- phase1BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease
- phase1BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic Malignancies
- phase1BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
- phase1Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Non-Hodgkin Lymphoma
- phase1LMY-920 for Treatment of Relapsed or Refractory Myeloma
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that